Negócios · 02/04/20191 min de leitura
New Animal Drugs; Approval of New Animal Drug Applications; Changes of Sponsorship
Tradução automática local · Idioma original da fonte
Resumo
The Food and Drug Administration (FDA or we) is amending the animal drug regulations to reflect application-related actions for new animal drug applications (NADAs) and abbreviated new animal drug applications (ANADAs) during October, November, and December 2018. FDA is informing the public of the availability of summaries of the basis of approval and of environmental review documents, where applicable. The animal drug regulations are also being amended to make technical amendments to improve the readability of the regulations.